Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Preclinical Data
Sort By
Newest First
1 / 1
1 / 1
Preclinical Data
Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene for the Treatment of Hereditary Angioedema
Poseida Therapeutics
PR-10-24-NI-63
Oct 25, 2024
Clinical Data
Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium
Skyhawk
PR-10-24-NI-62
Oct 25, 2024
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Mark Mintz; Kristen M. Eisenhauer
Charles River Laboratories
PAO-05-23-CL-03
May 05, 2023
Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
Cyrus Arman, Ph.D.
CytoDyn
PAO-02-23-CL-04
Feb 06, 2023
Antibodies
Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies
Twist Bioscience
PR-M11-20-022-1179
Nov 24, 2020
CAR-T Immunotherapy
Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells
Cabaletta Bio
PR-M10-19-NI-024
Oct 15, 2019
Diabetes
Preclinical Studies Bode Well for Diabetes Drug from Semma Therapeutics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-009
Jul 10, 2019
Cell and Gene Therapy
Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation Technology
Sangamo Therapeutics
PR-M04-19-NI-012
Apr 03, 2019
Preclinical Data
Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017
Nice Insight
PR-M03-19-NI-053
Mar 20, 2019
Preclinical Data
Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria
Artemis Therapeutics
PR-M06-18-NI-063
Jun 20, 2018
Preclinical Data
Recently Presented Preclinical Data Show Potential for ADXS-NEO as Anti-Cancer Immunotherapy Agent
Advaxis, Inc.
PR-M05-18-NI-056
May 15, 2018
